Your Messages Inbox
Your Article Summary
See Latest ArticlesNovartis to enter Japan vaccines market through agreement for Haemophilus Influenzae Type B (Hib) vaccine
Novartis, 05/27/09
Novartis announced that it has entered an agreement with the Takeda Pharmaceutical Company in Japan for the distribution of the Novartis Vaxem-Hib vaccine for the prevention of infection caused by Haemophilus influenzae type B (Hib). Through this agreement, Novartis will manufacture the vaccine and supply it to Takeda, which will obtain exclusive rights to license, market and distribute the vaccine in Japan.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Article Search
Sponsor